化纤复肝方抗肝纤维化的临床研究  

Clinical research on Huaxianfugan Prescription in treating hepatic fibrosis

作　　者：谢碧红[1] 杨觉民[1] 吴引伟[1] 

机构地区：[1]南京市第二医院中西医结合科,南京210003

出　　处：《天津中医药》2009年第2期108-109,共2页Tianjin Journal of Traditional Chinese Medicine

基　　金：江苏省科委社会发展基金资助项目(BS2005011)

摘　　要：[目的]观察中药化纤复肝方在抗肝纤维化方面的疗效。[方法]选取62例肝纤维化患者随机分为两组,治疗组32例,对照组30例,治疗6个月。观察治疗前后两组患者的症状、体征、肝功能及肝纤维化指标的变化,评价中药化纤复肝方抗肝纤维化的疗效。[结果]治疗组改善肝纤维化患者的症状、恢复肝功能、降低血清肝纤维化指标明显优于对照组(P<0.05)。[结论]化纤复肝方有比较良好的抗肝纤维化的效果。[Objective] To investigate the effect of Huaxianfugan Prescription in treating hepatic fibrosis. [Methods] Sixty-two cases with hepatic fibrosis were randomly divided into treatment group （32 cases） and control group （30 cases） with a course of treatment for 6 months. The symptoms, signs, liver function and the index of hepatic fibrosis were observed before and after treatment, and the effect of Huaxianfugan prescription in treating hepatic fibrosis was evaluated. [Results] The curative effect of treatment group was superior to that of control group in improving the symptoms and liver function, and decreasing the serum index of hepatic fibrosis （P〈0.05）. [Conclusion] Huaxianfugan Prescription has a good effect in anti-hepatic fibrosis.

关 键 词：肝纤维化 化纤复肝方 临床研究 

分 类 号：R285.5[医药卫生—中药学]